Physician profile
Michelle Fredricks
NPI 1912909250
$2,553.41
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $300 · 2021: $751 · 2022: $108.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $554.22 | 2019-2021 | |
| Amarin Pharma, INC. | $388.18 | 2019-2022 | |
| Csl Behring | $158.84 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $143.59 | 2019-2021 | |
| Amgen INC. | $126.87 | 2019-2021 | |
| Allergan, INC. | $96.92 | 2019-2020 | |
| Medtronic Vascular, INC. | $95.80 | 2019 | |
| Abbott Laboratories | $87.95 | 2019-2022 | |
| Glaxosmithkline, LLC. | $77.47 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.96 | 2021 | |
| Novo Nordisk INC | $76.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.56 | 2019 | |
| Neurocrine Biosciences, INC. | $61.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.10 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $43.70 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $42.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.96 | 2021 | |
| Upsher-Smith Laboratories LLC | $38.09 | 2019-2020 | |
| Pfizer INC. | $32.68 | 2019-2021 | |
| Akcea Therapeutics, INC. | $25.11 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.39 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $22.08 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.51 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.29 | 2022 | |
| Abbvie INC. | $20.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.70 | 2021 | |
| Boston Scientific Corporation | $18.86 | 2019 | |
| Lilly USA, LLC | $18.08 | 2022 | |
| Esperion Therapeutics, INC. | $17.69 | 2021 | |
| Vivus LLC | $16.45 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.31 | 2022 | |
| Horizon Therapeutics Plc | $14.72 | 2019 | |
| Kyowa Kirin, INC. | $14.49 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.43 | 2019 | |
| Sanofi Pasteur INC. | $11.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Fredricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.